HER2+ Breast Cancer NewsLatest News On HER2+ Breast Cancer Trastuzumab Emtansine Ups Long-Term Survival in HER2-Positive Breast Cancer1/16/2025 9:15 AM Immediate Surgery Significantly Improves Long-Term Survival in Older Breast Cancer Patients, Meta-Analysis Shows12/12/2024 4:24 AM Inside the Patient-Oncologist Bond: Why It’s Often So Strong11/26/2024 6:40 AM Q&A: HER2- Low Breast Cancer Pathophysiology and Evidence-Based Treatment Approaches10/17/2024 12:49 PM FDA OKs Adjuvant Ribociclib in Earlier Stage Breast Cancer9/19/2024 5:37 AM Trastuzumab Deruxtecan Shows Promise in HER2+ BC with Brain Metastases9/15/2024 12:42 PM T-DM1 Yields 'Outstanding' Long-Term Outcomes in Early HER2+ Breast Cancer7/29/2024 6:48 AM Eribulin Effective When Paired With Dual HER2 Blockade in BC7/12/2024 2:52 AM ASCO 2024: What's New in Breast Cancer Research?6/6/2024 10:08 AM Abemaciclib Combo Improves Survival in Advanced Breast Cancer6/6/2024 9:56 AM Gene Panel Predicts Early HER2+ Breast Cancer Prognosis5/20/2024 7:16 AM
